InflammaDry® is the only rapid, in-practice test to aid in dry eye diagnosis

Inflammation is linked to dry eye and is present in both symptomatic and asymptomatic patients.¹ Elevated MMP-9 levels act as a biomarker for inflammation and is more sensitive at detection than clinical signs alone.²

InflammaDry® recognises elevated levels of MMP-9 to identify patients that may otherwise be missed with other dry eye testing methods. InflammaDry® is the first and only, rapid, in-practice test that detects MMP-9, an inflammatory marker that is consistently elevated in the tears of patients with Dry Eye Disease. Commit to making the right diagnosis with an easy-to-use, in-practice, dry eye test that gives accurate results in as little as 10 minutes.

By identifying and treating patients with dry eye, pre-surgical measurements are more accurate and post surgical outcomes are improved. It also reduces post-surgical complications, such as corneal wound healing, by identifying dry eye prior to surgery. And the therapeutic treatment of dry eye will improve patient quality of life.